← Open Payments lookup

KATIE MANN: Open Payments

NPI 1780198655 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,028 in 97 payments from 17 companies in 2025. Trend: 2023 $2,223 · 2024 $2,118 · 2025 $2,028

Food & beverage: $1,916Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.10$330
ABBVIE INC.17$283
Vanda Pharmaceuticals Inc.12$251
Takeda Pharmaceuticals U.S.A., Inc.11$245
E.R. Squibb & Sons, L.L.C.8$146
Otsuka America Pharmaceutical, Inc.11$143
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$137
Almatica Pharma LLC6$137
Lundbeck LLC3$81
Axsome Therapeutics, Inc.3$61

Products named: VRAYLAR, FANAPT, TRINTELLIX, REXULTI, AUSTEDO XR, COBENFY, CAPLYTA, LOREEV XR.

Industry payments across FL — which companies pay providers there.